Indian Company Master Data Made Simple
Cipla Limited
Established in 1935, Cipla Limited has 91 years of operational experience. It is registered under CIN L24239MH1935PLC002380 and registration number 2380. Cipla Limited is identified as company limited by shares in the corporate registry. Cipla Limited is authorized to hold share capital worth ₹175.00 crore. The company’s paid-up capital is ₹161.52 crore.
Its principal business sector is manufacture of other chemical products. Cipla Limited is officially registered in Mumbai. The official address of incorporation is Cipla House, Peninsula Business Park Ganpatrao Kadam Marg, Lower Parel, Mumbai City, Mumbai, Maharashtra, India, 400013. It is officially listed as an active business entity. Cipla Limited is registered with the PAN code AAACC1450B. As per official records, the company’s LEI is 335800KMJJYEDDK82Q34. Its primary communication email is cosecretary@cipla.com. At the helm are Ashish Adukia (CFO).
Company Overview
- CIN
- Date of Incorporation
- 16/08/1935
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹1,75,00,00,000.00
- Paid up Capital
- ₹1,61,52,25,016.00
- Activity
- Manufacture of other chemical products
- cosecretary@cipla.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Andhra Pradesh | 37AAACC1450B1ZD | Active |
| Assam | 18AAACC1450B1ZD | Active |
| 18AAACC1450B3ZB | Inactive | |
| 18AAACC1450B2ZC | Inactive | |
| Bihar | 10AAACC1450B1ZT | Active |
| Chandigarh | 04AAACC1450B1ZM | Active |
| 04AAACC1450B3ZK | Inactive | |
| Chhattisgarh | 22AAACC1450B1ZO | Inactive |
| Dadra and Nagar Haveli and Daman and Diu | 26AAACC1450B1ZG | Active |
| Delhi | 07AAACC1450B1ZG | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE059A01026 | CIPLA LIMITED EQ NEW FV RS.2/- | - | 12/10/2026 | CIPLA LTD/SH VTG | ESVUFN |
| IN8059A01017 | CIPLA LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | CIPLA LTD/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹7,98,277.00L | ₹6,70,545.00L | ₹6,17,111.00L | ₹5,88,262.00L | ₹0.00L |
| Goodwill | ₹3,75,442.00L | ₹3,27,027.00L | ₹3,11,204.00L | ₹2,98,386.00L | ₹0.00L |
| Gross PPE | ₹14,16,282.00L | ₹12,15,320.00L | ₹11,02,493.00L | ₹10,46,732.00L | ₹0.00L |
| Inventory | ₹6,59,672.00L | ₹5,64,211.00L | ₹5,23,795.00L | ₹5,15,643.00L | ₹0.00L |
| Total Debt | ₹61,377.00L | ₹43,819.00L | ₹55,941.00L | ₹80,312.00L | ₹0.00L |
| Common Stock | ₹16,156.00L | ₹16,152.00L | ₹16,147.00L | ₹16,143.00L | ₹0.00L |
| Current Debt | ₹14,050.00L | ₹8,012.00L | ₹24,702.00L | ₹52,036.00L | ₹0.00L |
| Share Issued | ₹8,077.83L | ₹8,076.17L | ₹8,073.67L | ₹8,071.51L | ₹0.00L |
| Total Assets | ₹42,49,598.00L | ₹37,38,704.00L | ₹32,71,782.00L | ₹29,46,328.00L | ₹0.00L |
| Capital Stock | ₹16,156.00L | ₹16,152.00L | ₹16,147.00L | ₹16,143.00L | ₹0.00L |
| Long Term Debt | ₹11,747.00L | ₹1,198.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹24,14,703.00L | ₹23,28,852.00L | ₹19,44,141.00L | ₹17,27,495.00L | ₹0.00L |
| Prepaid Assets | ₹1,47,674.00L | ₹1,07,781.00L | ₹1,10,676.00L | ₹1,05,191.00L | ₹0.00L |
| Working Capital | ₹17,13,344.00L | ₹17,80,456.00L | ₹14,19,564.00L | ₹12,16,528.00L | ₹0.00L |
| Financial Assets | ₹0.00L | ₹1,176.00L | ₹831.00L | ₹0.00L | ₹0.00L |
| Invested Capital | ₹34,68,992.00L | ₹31,28,555.00L | ₹26,95,345.00L | ₹23,92,814.00L | ₹0.00L |
| Other Properties | ₹28.00L | ₹32.00L | ₹5,06,897.00L | ₹4,99,078.00L | ₹0.00L |
| Retained Earnings | ₹28,21,600.00L | ₹25,64,428.00L | ₹21,43,878.00L | ₹18,05,703.00L | ₹0.00L |
| Common Stock Equity | ₹34,43,195.00L | ₹31,19,345.00L | ₹26,70,643.00L | ₹23,40,778.00L | ₹0.00L |
| Net Tangible Assets | ₹27,58,145.00L | ₹26,20,706.00L | ₹21,99,339.00L | ₹18,89,378.00L | ₹0.00L |
| Tangible Book Value | ₹27,58,145.00L | ₹26,20,706.00L | ₹21,99,339.00L | ₹18,89,378.00L | ₹0.00L |
| Current Liabilities | ₹7,01,359.00L | ₹5,48,396.00L | ₹5,24,577.00L | ₹5,10,967.00L | ₹0.00L |
| Long Term Provisions | ₹15,756.00L | ₹14,869.00L | ₹12,926.00L | ₹10,216.00L | ₹0.00L |
| Stockholders Equity | ₹34,43,195.00L | ₹31,19,345.00L | ₹26,70,643.00L | ₹23,40,778.00L | ₹0.00L |
| Other Equity Interest | ₹6,250.00L | ₹11,412.00L | ₹8,654.00L | ₹6,180.00L | ₹0.00L |
| Total Capitalization | ₹34,54,942.00L | ₹31,20,543.00L | ₹26,70,643.00L | ₹23,40,778.00L | ₹0.00L |
| Hedging Assets Current | ₹158.00L | ₹955.00L | ₹2,543.00L | ₹921.00L | ₹0.00L |
| Investment Properties | ₹0.00L | ₹11,125.00L | ₹11,361.00L | ₹5,983.00L | ₹0.00L |
| Ordinary Shares Number | ₹8,077.83L | ₹8,076.17L | ₹8,073.67L | ₹8,071.51L | ₹0.00L |
| Other Intangible Assets | ₹3,09,608.00L | ₹1,71,612.00L | ₹1,60,100.00L | ₹1,53,014.00L | ₹0.00L |
| Other Non Current Assets | ₹65,722.00L | ₹43,759.00L | ₹29,725.00L | ₹25,817.00L | ₹0.00L |
| Total Non Current Assets | ₹18,34,895.00L | ₹14,09,852.00L | ₹13,27,641.00L | ₹12,18,833.00L | ₹0.00L |
| Cash And Cash Equivalents | ₹1,01,822.00L | ₹58,869.00L | ₹64,007.00L | ₹62,763.00L | ₹0.00L |
| Construction In Progress | ₹1,94,297.00L | ₹1,44,319.00L | ₹1,10,214.00L | ₹89,184.00L | ₹0.00L |
| Accumulated Depreciation | -₹6,18,005.00L | -₹5,44,775.00L | -₹4,85,382.00L | -₹4,58,470.00L | ₹0.00L |
| Additional Paid In Capital | ₹1,70,714.00L | ₹1,69,260.00L | ₹1,67,284.00L | ₹1,65,277.00L | ₹0.00L |
| Other Short Term Investments | ₹9,00,990.00L | ₹10,02,059.00L | ₹7,13,893.00L | ₹5,63,543.00L | ₹0.00L |
| Other Non Current Liabilities | ₹646.00L | ₹789.00L | ₹1,806.00L | ₹2,041.00L | ₹0.00L |
| Machinery Furniture Equipment | ₹8,38,618.00L | ₹7,29,296.00L | ₹6,60,969.00L | ₹6,20,874.00L | ₹0.00L |
| Derivative Product Liabilities | ₹18,041.00L | ₹3,081.00L | ₹4,383.00L | ₹3,924.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹6,85,050.00L | ₹4,98,639.00L | ₹4,71,304.00L | ₹4,51,400.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹34,52,024.00L | ₹31,28,925.00L | ₹26,80,233.00L | ₹23,71,354.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹7,97,574.00L | ₹6,09,779.00L | ₹5,91,549.00L | ₹5,74,974.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹23,182.00L | ₹18,572.00L | ₹33,399.00L | ₹59,430.00L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹38,195.00L | ₹25,247.00L | ₹22,542.00L | ₹20,882.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹10,02,812.00L | ₹10,60,928.00L | ₹7,77,900.00L | ₹6,26,306.00L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹96,215.00L | ₹61,383.00L | ₹66,972.00L | ₹64,007.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | ₹86,071.00L | ₹3,45,678.00L | ₹2,78,461.00L | ₹2,05,476.00L | ₹0.00L |
| Changes In Cash | ₹38,024.00L | ₹2,105.00L | -₹5,455.00L | -₹10,915.00L | ₹0.00L |
| End Cash Position | ₹1,01,539.00L | ₹54,265.00L | ₹51,234.00L | ₹56,133.00L | ₹0.00L |
| Financing Cash Flow | -₹1,23,365.00L | -₹1,29,279.00L | -₹1,20,043.00L | -₹95,829.00L | ₹0.00L |
| Investing Cash Flow | -₹2,32,613.00L | -₹3,69,114.00L | -₹2,98,803.00L | -₹2,38,851.00L | ₹0.00L |
| Operating Cash Flow | ₹3,94,002.00L | ₹5,00,498.00L | ₹4,13,391.00L | ₹3,23,765.00L | ₹0.00L |
| Capital Expenditure | -₹3,07,931.00L | -₹1,54,820.00L | -₹1,34,930.00L | -₹1,18,289.00L | ₹0.00L |
| Beginning Cash Position | ₹54,265.00L | ₹51,234.00L | ₹56,133.00L | ₹65,811.00L | ₹0.00L |
| Issuance Of Capital Stock | ₹4.00L | ₹5.00L | ₹4.00L | ₹7.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹5,27,186.00L | ₹6,86,483.00L | ₹5,77,303.00L | ₹4,13,291.00L | ₹0.00L |
| EBITDA | ₹6,35,548.00L | ₹7,86,028.00L | ₹6,82,405.00L | ₹5,15,210.00L | ₹0.00L |
| Net Income | ₹3,87,923.00L | ₹5,27,252.00L | ₹4,12,155.00L | ₹2,80,191.00L | ₹2,51,675.00L |
| Gross Profit | ₹17,25,960.00L | ₹17,38,266.00L | ₹15,85,425.00L | ₹13,51,255.00L | ₹0.00L |
| Pretax Income | ₹5,22,363.00L | ₹6,82,081.00L | ₹5,70,190.00L | ₹4,03,835.00L | ₹0.00L |
| Tax Provision | ₹1,35,384.00L | ₹1,52,976.00L | ₹1,54,659.00L | ₹1,20,286.00L | ₹0.00L |
| Total Revenue | ₹27,71,169.00L | ₹27,14,540.00L | ₹25,44,663.00L | ₹22,47,318.00L | ₹21,76,334.00L |
| Cost Of Revenue | ₹10,45,209.00L | ₹9,76,274.00L | ₹9,59,238.00L | ₹8,96,063.00L | ₹0.00L |
| Total Expenses | ₹22,86,617.00L | ₹21,00,118.00L | ₹20,07,797.00L | ₹18,45,531.00L | ₹0.00L |
| Interest Income | ₹20,694.00L | ₹26,440.00L | ₹21,959.00L | ₹16,224.00L | ₹0.00L |
| Interest Expense | ₹4,823.00L | ₹4,402.00L | ₹7,113.00L | ₹9,456.00L | ₹0.00L |
| Operating Income | ₹4,84,552.00L | ₹6,14,422.00L | ₹5,36,866.00L | ₹4,01,787.00L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹6,25,503.00L | ₹7,43,154.00L | ₹6,80,287.00L | ₹5,11,472.00L | ₹0.00L |
| Normalized Income | ₹3,80,481.66L | ₹4,93,994.64L | ₹4,10,611.40L | ₹3,08,616.26L | ₹0.00L |
| Operating Expense | ₹12,41,408.00L | ₹11,23,844.00L | ₹10,48,559.00L | ₹9,49,468.00L | ₹0.00L |
| Operating Revenue | ₹27,71,169.00L | ₹27,14,540.00L | ₹25,44,663.00L | ₹22,47,318.00L | ₹0.00L |
| Net Interest Income | ₹15,255.00L | ₹20,239.00L | ₹12,971.00L | ₹5,270.00L | ₹0.00L |
| Total Unusual Items | ₹10,045.00L | ₹42,874.00L | ₹2,118.00L | ₹3,738.00L | ₹0.00L |
| Total Other Finance Cost | ₹616.00L | ₹1,799.00L | ₹1,875.00L | ₹1,498.00L | ₹0.00L |
| Other Operating Expenses | ₹2,67,924.00L | ₹2,37,019.00L | ₹2,24,064.00L | ₹1,81,902.00L | ₹0.00L |
| Reconciled Depreciation | ₹1,08,362.00L | ₹99,545.00L | ₹1,05,102.00L | ₹1,01,919.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹10,45,209.00L | ₹9,76,274.00L | ₹9,59,238.00L | ₹8,96,063.00L | ₹0.00L |
| Rent Expense Supplemental | ₹12,921.00L | ₹11,184.00L | ₹9,265.00L | ₹8,686.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹2,603.66L | ₹9,616.64L | ₹574.40L | -₹4,320.74L | ₹0.00L |
| Interest Income Non Operating | ₹20,694.00L | ₹26,440.00L | ₹21,959.00L | ₹16,224.00L | ₹0.00L |
| Selling And Marketing Expense | ₹1,93,424.00L | ₹1,83,486.00L | ₹1,72,497.00L | ₹1,69,430.00L | ₹0.00L |
| Interest Expense Non Operating | ₹4,823.00L | ₹4,402.00L | ₹7,113.00L | ₹9,456.00L | ₹0.00L |
| Net Income Common Stockholders | ₹3,87,923.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Continuous Operations | ₹3,86,174.00L | ₹5,26,920.00L | ₹4,15,372.00L | ₹2,83,289.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹3,87,923.00L | ₹5,27,252.00L | ₹4,12,155.00L | ₹2,80,191.00L | ₹0.00L |
| General And Administrative Expense | ₹1,15,199.00L | ₹1,12,016.00L | ₹1,05,899.00L | ₹92,814.00L | ₹0.00L |
| Selling General And Administration | ₹3,08,623.00L | ₹2,95,502.00L | ₹2,78,396.00L | ₹2,62,244.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹10,045.00L | ₹42,874.00L | ₹2,118.00L | -₹14,504.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹15,255.00L | ₹20,239.00L | ₹12,971.00L | ₹5,270.00L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹3,86,174.00L | ₹5,26,920.00L | ₹4,15,372.00L | ₹2,83,289.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹3,87,923.00L | ₹5,27,252.00L | ₹4,12,155.00L | ₹2,80,191.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹3,87,923.00L | ₹5,27,252.00L | ₹4,12,155.00L | ₹2,80,191.00L | ₹0.00L |
Company Performance (FY22–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 21/07/1972 | Yusuf Khwaja Hamied | 00029049 | Director | View other directorships |
| 23/07/2014 | Adil Zainulbhai | 06646490 | Director | View other directorships |
| 01/09/2016 | Umang Vohra | 02296740 | Managing Director | View other directorships |
| 09/02/2017 | Rajendra Kumar Chopra | *****7408A | Company Secretary | |
| 14/05/2021 | Robert Stewart | 03515778 | Director | View other directorships |
| 01/07/2021 | Prathivadibhayankara Rajagopalan Ramesh | 01915274 | Director | View other directorships |
| 29/07/2022 | Mandar Purushottam Vaidya | 09690327 | Director | View other directorships |
| 16/08/2022 | Ashish Adukia | *****4709Q | CFO | |
| 01/04/2024 | Balram Bhargava | 10479707 | Director | View other directorships |
| 01/09/2024 | Sharmila Nitin Paranjpe | 02328770 | Director | View other directorships |
| 03/09/2024 | Abhijit Jagdish Joshi | 07115673 | Director | View other directorships |
| 01/11/2024 | Kamil Hamied | 00024292 | Director | View other directorships |
| 01/11/2024 | Maya Hari | 01123969 | Director | View other directorships |
Business Network
Directors 13
- Umang VohraManaging Director
- Kamil HamiedDirector
- Maya HariDirector
- Abhijit Jagdish JoshiDirector
- Sharmila Nitin ParanjpeDirector
- Balram BhargavaDirector
- Mandar Purushottam VaidyaDirector
- Prathivadibhayankara Rajagopalan RameshDirector
- Robert StewartDirector
- Adil ZainulbhaiDirector
- Yusuf Khwaja HamiedDirector
- Ashish AdukiaCFO
- Rajendra Kumar ChopraCompany Secretary
Subsidiaries 9
- Cipla Pharma And Life Sciences LimitedDirect
- Meditab Specialities LimitedDirect
- Cipla Health LimitedDirect
- Goldencross Pharma LimitedDirect
- Cipla Pharmaceuticals LimitedDirect
- Jay Precision Pharmaceuticals Private LimitedDirect
- Invagen Pharmaceuticals Inc.Direct
- Sitec Labs LimitedUltimate
- Medispray Laboratories Private LimitedUltimate
Latest Documents
| Date | Title | Size |
|---|---|---|
| 07/11/2024 | Form MGT-7-18102024 | - |
| 17/09/2024 | Form AOC-4(XBRL)-17092024_signed | - |
| 29/03/2024 | Form Addendum to AOC-4 CSR-29032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Cipla Pharma And Life Sciences Limited | 3358001Y1AJDOWP1QB25 |
| Direct | Meditab Specialities Limited | 33580024IOVCZFQ5NR86 |
| Direct | Cipla Health Limited | 335800EF1UKQE25U5930 |
| Direct | Goldencross Pharma Limited | 335800FZPXFBC1JOSI39 |
| Direct | Cipla Pharmaceuticals Limited | 335800H17JGFR4CI7G31 |
| Direct | Jay Precision Pharmaceuticals Private Limited | 335800NB8KVI4IXDUP33 |
| Direct | Invagen Pharmaceuticals Inc. | 549300PSQTOK7P8ZE722 |
| Ultimate | Sitec Labs Limited | 335800841DBDRFYJ1H47 |
| Ultimate | Medispray Laboratories Private Limited | 335800EIIXYBDM65HX19 |
Address
Frequently Asked Questions
The current board member of Cipla Limited are:
- Umang Vohra
- Prathivadibhayankara Rajagopalan Ramesh
- Mandar Purushottam Vaidya
- Yusuf Khwaja Hamied
- Adil Zainulbhai
- Robert Stewart
- Kamil Hamied
- Maya Hari
- Abhijit Jagdish Joshi
- Sharmila Nitin Paranjpe
- Balram Bhargava